Page last updated: 2024-08-24

ziprasidone and Torsade de Pointes

ziprasidone has been researched along with Torsade de Pointes in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (66.67)	29.6817
2010's	3 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alipour, A; Cruz, R; Lott, RS	1
Correll, CU; Figen, V; Kane, JM; Lops, JD; Malhotra, AK; Manu, P	1
Nielsen, J	1
Taylor, D	1
Martel, ML	1
Citrome, L; Volavka, J	1
Finzel, M; Fric, M; Laux, G	1
Brown, FW; Greco, KE; Tune, LE; Van Horn, WA	1
Hoffman, RS; Manini, AF; Nelson, LS; Raspberry, D	1

Reviews

2 review(s) available for ziprasidone and Torsade de Pointes

Article	Year
Ziprasidone in the management of schizophrenia : the QT interval issue in context. CNS drugs, 2003, Volume: 17, Issue:6 Topics: Antipsychotic Agents; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Piperazines; Risk Assessment; Risk Factors; Schizophrenia; Sex Factors; Thiazoles; Torsades de Pointes	2003
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning. Postgraduate medicine, 2004, Volume: 116, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain	2004

Article

Year

Ziprasidone in the management of schizophrenia : the QT interval issue in context.

CNS drugs, 2003, Volume: 17, Issue:6

Topics: Antipsychotic Agents; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Piperazines; Risk Assessment; Risk Factors; Schizophrenia; Sex Factors; Thiazoles; Torsades de Pointes

2003

The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.

Postgraduate medicine, 2004, Volume: 116, Issue:4

Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain

2004

Trials

1 trial(s) available for ziprasidone and Torsade de Pointes

Article	Year
[QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey]. Psychiatrische Praxis, 2004, Volume: 31 Suppl 1 Topics: Antipsychotic Agents; Electrocardiography; Germany; Hospitalization; Hospitals, Psychiatric; Humans; Long QT Syndrome; Piperazines; Prospective Studies; Psychotic Disorders; Risk Assessment; Thiazoles; Torsades de Pointes	2004

Other Studies

6 other study(ies) available for ziprasidone and Torsade de Pointes

Article	Year
Torsade de pointes after ziprasidone overdose with coingestants. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:1 Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Drug Overdose; Female; Humans; Long QT Syndrome; Middle Aged; Piperazines; Thiazoles; Torsades de Pointes	2010
QT interval duration and dispersion in children and adolescents treated with ziprasidone. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:6 Topics: Adolescent; Antipsychotic Agents; Child; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Male; Piperazines; Potassium; Thiazoles; Torsades de Pointes	2011
The safety of atypical antipsychotics: does QTc provide all the answers? Expert opinion on drug safety, 2011, Volume: 10, Issue:3 Topics: Antipsychotic Agents; Humans; Long QT Syndrome; Piperazines; Thiazoles; Torsades de Pointes	2011
Ziprasidone for sedation of the agitated ED patient. The American journal of emergency medicine, 2004, Volume: 22, Issue:3 Topics: Antipsychotic Agents; Droperidol; Drug Labeling; Emergency Treatment; Humans; Long QT Syndrome; Piperazines; Practice Guidelines as Topic; Psychomotor Agitation; Thiazoles; Torsades de Pointes; United States; United States Food and Drug Administration	2004
A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:7 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Arrhythmias, Cardiac; Dementia; Electrocardiography; Female; Haloperidol; Humans; Injections, Intramuscular; Long QT Syndrome; Male; Middle Aged; Piperazines; Psychomotor Agitation; Retrospective Studies; Risk Factors; Thiazoles; Torsades de Pointes	2005
QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2007, Volume: 3, Issue:4 Topics: Adult; Amantadine; Analgesics, Non-Narcotic; Antipsychotic Agents; Drug Overdose; Drug Therapy, Combination; Electrocardiography; Fatal Outcome; Female; Humans; Ibuprofen; Long QT Syndrome; Piperazines; Suicide, Attempted; Thiazoles; Torsades de Pointes	2007